http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110187112-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57446 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2019-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110187112-B |
| titleOfInvention | Cardia adenocarcinoma auxiliary diagnosis kit related to group of genes |
| abstract | A cardia adenocarcinoma auxiliary diagnosis kit related to a group of genes belongs to the technical field of biomedicine and molecular biology, and particularly relates to an ELISA kit for auxiliary diagnosis of cardia adenocarcinoma, which comprises a solid phase carrier and 6 antibodies respectively coated on the solid phase carrier, wherein the 6 antibodies are respectively: BCL2L1 antibody, DLC1 antibody, CDKN2A antibody, CDKN2B antibody, NRG1 antibody, Erb B4 antibody. Experiments prove that the group of related gene expression products are highly expressed in the serum of a patient with the cardiac adenocarcinoma, the expression level of the related gene in the serum of a human body is detected by an ELISA kit, and the detection result can be used for the early screening, prognosis evaluation and other auxiliary diagnosis of the cardiac adenocarcinoma, and has profound clinical significance and important popularization and application prospects. |
| priorityDate | 2019-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 168.